M&A and equity raisings

6,065 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

US deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

124 deals · US$156bndisclosed · Biotech · Clear

Columns
M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Feb 2025 Instinct Bio Technical Company –Relativity Acquisition SponsorMergerPending225.0Biotech Hunter Taubman Fischer & Li (sell-side)Chardan (sell-side)Loeb & Loeb (buy-side)Ogier (buy-side)
Jul 2025 DiamiR Biosciences Corp. –Aptorum GroupMergerCompleted–Diagnostics+1 H.C. Wainwright & Co. (sell-side)
Oct 2025 Astria Therapeutics –BioCryst PharmaceuticalsAcquisitionCompleted700.0Biotech+2 Evercore (sell-side)Sidley Austin (sell-side)BofA Securities (buy-side)Covington & Burling (buy-side)
Oct 2025 Avidity Biosciences –NovartisAcquisitionAnnounced11,000.0Biotech+2 Goldman Sachs (sell-side)Barclays (sell-side)Kirkland & Ellis (sell-side)Covington & Burling (buy-side)Freshfields (buy-side)Gordon Dyal & Co. (buy-side)
Nov 2025 Aptose Biosciences –HS North AmericaAcquisitionAnnounced–Biotech+2 Locust Walk (sell-side)Stikeman Elliott (buy-side)
Dec 2025 MindWave Innovations –Apimeds Pharmaceuticals USMergerCompleted–Biotech+1 Duane Morris (sell-side)Nelson Mullins Riley & Scarborough (buy-side)
Dec 2025 Generation Bio Co. –XRA 7 Corp.AcquisitionAnnounced–Biotech+1 TD Securities (sell-side)WilmerHale (sell-side)Gibson Dunn (buy-side)
Dec 2025 Amicus Therapeutics –BioMarinAcquisitionAnnounced4,800.0Biotech+2 Centerview Partners (sell-side)Goldman Sachs (sell-side)Kirkland & Ellis (sell-side)Morgan Stanley (buy-side)Jones Day (buy-side)
Dec 2025 Dynavax Technologies –SanofiAcquisitionAnnounced2,200.0Biotech+1 Centerview Partners (sell-side)Goldman Sachs (sell-side)Cooley (sell-side)Weil, Gotshal & Manges (buy-side)
2026 Calytrix Bio –Eli LillyAcquisitionAnnounced1,500.0Biotech Centerview Partners (sell-side)
2026 AttaiBeckley –Eli Lilly and CompanyAcquisitionAnnounced3,800.0Biotech+2 Moelis & Company (sell-side)
2026 FireFly Biologics –J&JAcquisitionAnnounced1,000.0Biotech+1 Centerview Partners (sell-side)
Jan 2026 Dark Blue Therapeutics –AmgenAcquisitionCompleted840.0Biotech+2 Goodwin (sell-side)BofA Securities (sell-side)
Jan 2026 Mersana Therapeutics –Day One BiopharmaceuticalsAcquisitionCompleted–Biotech+2 TD Securities (sell-side)WilmerHale (sell-side)Gordon Dyal & Co. (buy-side)Fenwick & West (buy-side)
Jan 2026 Ventyx Biosciences –Eli Lilly and CompanyAcquisitionAnnounced1,200.0Biotech+2 Jefferies (sell-side)Moelis & Company (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)BofA Securities (buy-side)Ropes & Gray (buy-side)
Jan 2026 InduPro Therapeutics –Eli Lilly and CompanyStakeAnnounced–Biotech+2 Freshfields (buy-side)
Jan 2026 SL Bio –Horizon Space Acquisition II Corp.MergerAnnounced5,568.0Biotech VCL Law (sell-side)Ogier (sell-side)King Kee Appraisal and Advisory (buy-side)Robinson & Cole (buy-side)Maples Group (buy-side)
Jan 2026 AbelZeta's 50% share of China development and commercialisation rights to C-CAR031 AbelZetaAstraZenecaAsset saleAnnounced630.0Biotech+2 Davis Polk (sell-side)
Jan 2026 RAPT Therapeutics –GSKAcquisitionAnnounced2,200.0Biotech+1 J.P. Morgan (sell-side)Cooley (sell-side)Latham & Watkins (sell-side)Evercore (buy-side)A&O Shearman (buy-side)
Jan 2026 Repare Therapeutics –XenoTherapeuticsAcquisitionCompleted–Biotech+1 Cooley (sell-side)Stikeman Elliott (sell-side)
Feb 2026 PrimeGen US –DT Cloud Star AcquisitionMergerAnnounced1,500.0Biotech+1 A.G.P./Alliance Global Partners (sell-side)Sichenzia Ross Ference Carmel (sell-side)Loeb & Loeb (buy-side)
Feb 2026 Orna Therapeutics –Eli Lilly and CompanyAcquisitionAnnounced2,400.0Biotech+1 Lazard (sell-side)Goodwin (sell-side)Paul, Weiss (buy-side)
Feb 2026 Avadel Pharmaceuticals –AlkermesSchemeCompleted–Pharma+1 Goldman Sachs (sell-side)Morgan Stanley (sell-side)J.P. Morgan (buy-side)
Feb 2026 Faeth Therapeutics –Sensei BiotherapeuticsAcquisitionCompleted–Biotech+2 Cooley (sell-side)Lucid Capital Markets (buy-side)Sidley Austin (buy-side)
Feb 2026 Arcellx –Gilead SciencesAcquisitionAnnounced7,800.0Biotech+2 Centerview Partners (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)BofA Securities (buy-side)Morgan Stanley (buy-side)Ropes & Gray (buy-side)Innisfree M&A (buy-side)
Feb 2026 35Pharma –GSKAcquisitionAnnounced950.0Biotech+1 Cooley (sell-side)Centerview Partners (sell-side)Paul, Weiss (buy-side)
Feb 2026 AiCuris Anti-infective Cures AG –Veloxis PharmaceuticalsAcquisitionAnnounced913.0Pharma+1 Gibson Dunn (sell-side)Freshfields (buy-side)
Feb 2026 Precision NeuroMed –Brainlab SEStakeCompleted–Biotech+2 Sidley Austin (sell-side)
Mar 2026 Transcend Therapeutics –OtsukaAcquisitionAnnounced700.0Biotech+2 Kirkland & Ellis (sell-side)Goodwin (sell-side)Centerview Partners (sell-side)Skadden, Arps, Slate, Meagher & Flom (buy-side)
Mar 2026 Cullgen –Gyre TherapeuticsAcquisitionPending300.0Biotech+1 Mintz (sell-side)Moelis & Company (buy-side)Gibson Dunn (buy-side)
Mar 2026 Candid Therapeutics –RallybioAcquisitionPending–Biotech+1 Wedbush Securities (sell-side)Cooley (sell-side)Evercore (buy-side)Citizens JMP (buy-side)Ropes & Gray (buy-side)
Mar 2026 Unleash-owned rights to UIO-524, UIO-525 and UIO-526 Unleash Immuno OncolyticsTransCode TherapeuticsAsset salePending–Biotech+2 Tungsten Advisors
Mar 2026 Lisata Therapeutics –Kuva LabsAcquisitionPending–Biotech+2 Mintz (sell-side)H.C. Wainwright & Co. (sell-side)Goodwin (buy-side)Campaign Management (buy-side)
Mar 2026 Day One Biopharmaceuticals –ServierAcquisitionPending2,500.0Biotech+2 Centerview Partners (sell-side)Fenwick & West (sell-side)Goldman Sachs (buy-side)Baker McKenzie (buy-side)Innisfree M&A (buy-side)
Mar 2026 Pikavation SynnovationNovartisAcquisitionAnnounced2,000.0Biotech+2 Goodwin (sell-side)Centerview Partners (sell-side)
Mar 2026 Ouro Medicines –GileadAcquisitionAnnounced1,675.0Biotech+1 Paul, WeissGoodwin (sell-side)Centerview Partners (buy-side)
Mar 2026 Terns Pharmaceuticals –Merck & Co.AcquisitionAnnounced6,700.0Biotech+2 Centerview Partners (sell-side)Freshfields (sell-side)Jefferies (sell-side)Covington & Burling (buy-side)Gibson Dunn (buy-side)
Mar 2026 Eos SENOLYTIX –PulmatrixMergerAnnounced–Biotech+1 Palladium Capital Group (buy-side)Evolution Venture Partners (sell-side)Wilk Auslander (sell-side)Gemini Valuation Services (buy-side)Haynes Boone (buy-side)
Mar 2026 AnaptysBio outstanding common stock –AnaptysBioBuy-backAnnounced100.0Biotech+1 Piper Sandler (buy-side)
Mar 2026 Kezar Life Sciences –Aurinia PharmaceuticalsAcquisitionAnnounced51.5Biotech+1 TD Securities (sell-side)Cooley (sell-side)
Mar 2026 Apellis Pharmaceuticals –BiogenAcquisitionAnnounced5,600.0Biotech+2 Lazard (buy-side)Evercore (sell-side)Wachtell, Lipton, Rosen & Katz (sell-side)WilmerHale (sell-side)Cravath, Swaine & Moore (buy-side)
Mar 2026 Centessa Pharmaceuticals –Eli Lilly and CompanySchemePending6,300.0Biotech+1 Centerview Partners (sell-side)Jefferies (sell-side)Goodwin (sell-side)Morgan Stanley (buy-side)Kirkland & Ellis (buy-side)
Apr 2026 Modeyso commercial sales royalties Former Oncoceutics Inc. securityholdersHealthCare RoyaltyAsset saleAnnounced–Specialty finance and leasing+3 Latham & Watkins (sell-side)
Apr 2026 Exclusive global rights to TAK-063 (balipodect) Takeda Pharmaceutical Co.Axsome TherapeuticsAsset saleCompleted–Pharma+1 Sidley Austin (buy-side)
Apr 2026 Soleno Therapeutics –Neurocrine BiosciencesAcquisitionCompleted2,900.0Biotech+2 Centerview Partners (sell-side)Guggenheim Securities (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)Goodwin (sell-side)Goldman Sachs (buy-side)Cooley (buy-side)
Apr 2026 Tubulis EQT Life Sciences (LSP 7 fund)Gilead SciencesAcquisitionAnnounced3,150.0Biotech+2 Goodwin (sell-side)J.P. Morgan (sell-side)CMS (sell-side)Centerview Partners (buy-side)Allen & Company (buy-side)Covington & Burling (buy-side)Arnold & Porter (buy-side)Venable (buy-side)
Apr 2026 CrossBridge Bio –Eli Lilly and CompanyAcquisitionAnnounced300.0Biotech+2 Cooley (sell-side)
Apr 2026 Obsidian Therapeutics –Galera TherapeuticsMergerCompleted413.5Biotech+2 Goodwin (sell-side)Sidley Austin (buy-side)Leerink Partners (sell-side)Lucid Capital Markets (buy-side)
Apr 2026 Neurona Therapeutics –UCBAcquisitionAnnounced650.0Biotech+2 Centerview Partners (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)BofA Securities (buy-side)Covington & Burling (buy-side)
Apr 2026 Kelonia Therapeutics –Eli Lilly and CompanyAcquisitionAnnounced7,000.0Biotech+2 Goodwin (sell-side)Jefferies (sell-side)Kirkland & Ellis (buy-side)

Deals come from stock exchange announcements and filings, takeover and scheme documents, prospectuses, the advisers' own deal announcements and the press. How the data is built All countries counts every deal, wherever it is, including deals whose geography is not known.Country pages cover Australia, New Zealand and the United States. The United Kingdom, Canada, Singapore, China and India are planned.